Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.

MLA

Kandzari, David E., et al. “Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in US Patients Undergoing Coronary Revascularization: 1-Year Outcomes from the BIOFLOW VII Trial.” Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, vol. 102, no. 3, Sept. 2023, pp. 464–71. EBSCOhost, https://doi.org/10.1002/ccd.30783.

APA

Kandzari, D. E., Garcia-Garcia, H. M., Stoler, R. C., Wang, J., Picone, M., Ben-Dor, I., & Garcia, S. A. (2023). Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial. Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, 102(3), 464–471. https://doi.org/10.1002/ccd.30783

Chicago

Kandzari, David E, Hector M Garcia-Garcia, Robert C Stoler, John Wang, Mark Picone, Itsik Ben-Dor, and Santiago A Garcia. 2023. “Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in US Patients Undergoing Coronary Revascularization: 1-Year Outcomes from the BIOFLOW VII Trial.” Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 102 (3): 464–71. doi:10.1002/ccd.30783.